-The Times of India NEW DELHI: Marginal farmers in Maharashtra are battling another cruel drought. In Vidarbha, droughts have become an annual feature. Absence of irrigation and efficient watershed management make small farmers even more vulnerable. Although schemes such as the Mahatma Gandhi Rural Employment Guarantee Act (MGNREGA), Swarnajayanti Gram Swarozgar Yojana or the Indira Awaas Yojana are not viewed as adaptation policies, many agree they play an important role in making...

-The Times of India NEW DELHI: An environment survey carried out across six metropolitan cities by The Energy and Resources Institute has found that while 80% of the respondents in Delhi believe that the overall environment in the city has deteriorated in the past five years, the capital also sets the record for being the most ill-informed across the metros about government policies on environment. Teri interviewed 1,114 respondents in Delhi NCR...

-PTI NEW DELHI: India's economic development has led to the worsening of air quality in major Indian cities, according to the results of a survey by The Energy and Resources Institute (Teri) in Bangalore, Chennai, Delhi, Hyderabad, Kolkata and Mumbai. The transport sector was ranked the highest followed by factories in and around the city as the second highest contributor towards air pollution in Chennai, Delhi, Kolkata, and Mumbai. While respondents from Bangalore...

-Economic and Political Weekly   A report on the 2013 deliberation of the Kolkata Group at its 10th workshop which focused on healthcare, the status of women and social justice in India. A K Shiva Kumar (akshivakumar@gmail.com) is convener of the Kolkata Group workshops which are organised by Pratichi (India) Trust, the Harvard Global Equity Initiative and UNICEF India. At the 10th annual Kolkata Group workshop in February this year, 40 policymakers, development practitioners,...

-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...